 |
PDBsum entry 3d23
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
3d23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Main protease of hcov-hku1
|
|
Structure:
|
 |
3c-like proteinase. Chain: b, a, c, d. Engineered: yes. N-[(5-methylisoxazol-3-yl)carbonyl]alanyl-l-valyl-n~1~- ((1r,2z)-4-(benzyloxy)-4-oxo-1-{[(3r)-2-oxopyrrolidin-3- yl]methyl}but-2-enyl)-l-leucinamide. Chain: h, f, e, g. Engineered: yes
|
|
Source:
|
 |
Human coronavirus. Hcov-hku1. Organism_taxid: 443239. Strain: hku1. Gene: rep. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Synthetic construct.
|
|
Resolution:
|
 |
|
2.50Å
|
R-factor:
|
0.232
|
R-free:
|
0.285
|
|
|
Authors:
|
 |
Q.Zhao,C.Chen,S.Li,Y.Zou
|
|
Key ref:
|
 |
Q.Zhao
et al.
(2008).
Structure of the main protease from a global infectious human coronavirus, HCoV-HKU1.
J Virol,
82,
8647-8655.
PubMed id:
|
 |
|
Date:
|
 |
|
07-May-08
|
Release date:
|
16-Sep-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P0C6U3
(R1A_CVHN1) -
Replicase polyprotein 1a from Human coronavirus HKU1 (isolate N1)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
4471 a.a.
301 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.2.7.7.50
- mRNA guanylyltransferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 5'-end diphospho-ribonucleoside in mRNA + GTP + H+ = a 5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA + diphosphate
|
 |
 |
 |
 |
 |
5'-end diphospho-ribonucleoside in mRNA
|
+
|
GTP
|
+
|
H(+)
|
=
|
5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.3.4.19.12
- ubiquitinyl hydrolase 1.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Thiol-dependent hydrolysis of ester, thiolester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.3.4.22.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
E.C.3.4.22.69
- Sars coronavirus main proteinase.
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
J Virol
82:8647-8655
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of the main protease from a global infectious human coronavirus, HCoV-HKU1.
|
|
Q.Zhao,
S.Li,
F.Xue,
Y.Zou,
C.Chen,
M.Bartlam,
Z.Rao.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The newly emergent human coronavirus HKU1 (HCoV-HKU1) was first identified in
Hong Kong in 2005. Infection by HCoV-HKU1 occurs worldwide and causes syndromes
such as the common cold, bronchitis, and pneumonia. The CoV main protease
(M(pro)), which is a key enzyme in viral replication via the proteolytic
processing of the replicase polyproteins, has been recognized as an attractive
target for rational drug design. In this study, we report the structure of
HCoV-HKU1 M(pro) in complex with a Michael acceptor, inhibitor N3. The structure
of HCoV-HKU1 provides a high-quality model for group 2A CoVs, which are distinct
from group 2B CoVs such as severe acute respiratory syndrome CoV. The structure,
together with activity assays, supports the relative conservation at the P1
position that was discovered by sequencing the HCoV-HKU1 genome. Combined with
structural data from other CoV M(pro)s, the HCoV-HKU1 M(pro) structure reported
here provides insights into both substrate preference and the design of
antivirals targeting CoVs.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.R.Gaunt,
A.Hardie,
E.C.Claas,
P.Simmonds,
and
K.E.Templeton
(2010).
Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method.
|
| |
J Clin Microbiol,
48,
2940-2947.
|
 |
|
|
|
|
 |
S.C.Cheng,
G.G.Chang,
and
C.Y.Chou
(2010).
Mutation of Glu-166 blocks the substrate-induced dimerization of SARS coronavirus main protease.
|
| |
Biophys J,
98,
1327-1336.
|
 |
|
|
|
|
 |
S.Fang,
H.Shen,
J.Wang,
F.P.Tay,
and
D.X.Liu
(2010).
Functional and genetic studies of the substrate specificity of coronavirus infectious bronchitis virus 3C-like proteinase.
|
| |
J Virol,
84,
7325-7336.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |